Elanco Animal Health Inc (NYSE:ELAN)
$ 14.07 -0.43 (-2.97%) Market Cap: 6.96 Bil Enterprise Value: 10.82 Bil PE Ratio: 35.18 PB Ratio: 1.07 GF Score: 72/100

Elanco Animal Health Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 15, 2020 / 06:00PM GMT
Release Date Price: $26.84 (-2.89%)
David Reed Risinger
Morgan Stanley, Research Division - MD in Equity Research and United States Pharmaceuticals Analyst

Great. So good afternoon, everyone. Thank you for joining us. This is Dave Risinger. And I cover both major and specialty pharmaceuticals at Morgan Stanley. I need to refer you to disclaimers at www.morganstanley.com/researchdisclosures. And if you're a member of the press, please disconnect and contact the Morgan Stanley Public relations office.

So I am very pleased to welcome Jeff Simmons, who is the CEO of Elanco. As the Head of Elanco Animal Health for the past decade, he's directed the company's transformation into a premier global player, now 2, #2 in the business. With a balance of diversified businesses, Jeff has overseen the completion of 12 acquisitions, built 5 new businesses, including the $1 billion-plus Companion Animal business, and also a leading aquaculture operation. So we're very pleased to have Jeff with us today. Jeff, let me turn it over to you for some opening

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot